Latest News Archive

Please select Category, Year, and then Month to display items

Kovsies crowned 2024 Varsity Netball champions after thrilling extra-time win

08 October 2024 | Story Leonie Bolleurs | Photo Francois van Vuuren, iFlair

UFS the 2024 Varsity Netball Champions — In a high-stakes showdown, the Kovsie netball team secured its fifth Varsity Netball title, edging out the University of Johannesburg (UJ) with a final score of 58-55.

After another nail-biting game in the 2024 Varsity Netball Tournament finals, Kovsies beat the University of Johannesburg (UJ) 58-55 at the Callie Human Centre on the Bloemfontein Campus of the University of the Free State (UFS) on 7 October 2024, earning them the title of 2024 Varsity Netball champions.

In an electrifying atmosphere – with strong support from fans in the stands – the Kovsie team, captained by Refiloe Nketsa, delivered a stellar performance, securing their fifth title. The game was tied 47-47 at full time and went into extra time, showcasing the team’s will and determination to win.

“Congratulations to our netball team for its fantastic performance not only during the final, but also throughout the tournament. The final was an amazing display of resilience, and we are proud of what the team achieved. I salute our champions on behalf of the entire university community. Under the leadership of the head coach Burta de Kock, the rest of the coaching staff, and captain Nketsa, the team worked hard, and their courage and commitment paid off,” said Prof Anthea Rhoda, acting Vice-Chancellor and Principal of the UFS.

“We would also like to acknowledge and thank the staff of KovsieSport under the leadership of Jerry Laka, Director of KovsieSport, for their significant contribution to the success of the team,” added Prof Rhoda.

Playing with heart and tenacity

Although the UFS started as favourites – having won the title in 2013, 2014, 2018, and 2021 – UJ played with heart and tenacity, fighting fiercely to claim the win. Both teams pushed their limits, with Kovsies leading by two points in the first few minutes. The score at the end of the first quarter was a close 13-12 in favour of the UFS.

In the second quarter, UJ fought back to close the gap, but Kovsies pulled ahead, leading by three points. They ended the quarter with Kovsies at 23 and UJ at 21. The third quarter saw the teams neck and neck, ending 35-34 in Kovsies’ favour. UJ briefly took the lead in the fourth quarter, but Kovsies rallied, reclaiming advantage and breaking through a tie of 47-47 to secure a victory of 58-55 in extra time.

Supporting the team from the side was head coach De Kock, Spar Proteas captain Khanyisa Chawane, Proteas vice-captain Karla Pretorius, team manager Ané Retief – who is part of the Protea squad that will represent South Africa at the Fast5 World Series in New Zealand in November, Sikholiwe Mdletshe, analysing coach, and Jason Carlisle, conditioning coach.

Coach De Kock, reflecting on the UFS team’s victory in the Varsity Netball finals, said, "We are very excited and grateful for God’s blessings and grace. We have an incredible group of players who are fully committed to the system. They understood their responsibilities on the court, and it was amazing to see that through. The players are also in top physical condition. We have a support framework within KovsieNetball, with everyone playing a role in helping the players succeed." She is also grateful to KovsieSport and the UFS for their hard work in preparing the venue and ensuring that the finals were a success.

‘Our players stood together’

De Kock attributed the team’s success to the unity they displayed on the court. "No player panicked when we lost the ball. Our players simply stood together and regained possession. We’re grateful for the incredible character the players demonstrated tonight."

With Kovsies claiming the title, the UFS this year reigns as Varsity Netball as well as Varsity Cup rugby champions. In April, the UFS Shimlas beat the UCT Ikeys 45-42 in the final on Shimla Park in Bloemfontein.

• Player of the Match: Refiloe Nketsa (UFS Kovsies captain)

• FNB Player of the Tournament: Rolene Streutker (UFS Kovsies)

• The team that played in the finals are: Liamé de Lange, Demi-Leigh de Jager, Megan Erasmus, Xandri Fourie, Elri Groenewald, Reratilwe Ke-Morena Letsoalo, Asanele Malgas, Owami Mohuli, Refiloe Nketsa, Rolene Streutker, Charné van Vuuren, Karla Victor.

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept